Voiant Acquires Voxeleron
August 2, 2025
Voiant has acquired Voxeleron, an AI-driven ophthalmic image analysis company, to integrate advanced AI/ML imaging capabilities into its clinical trial imaging platform. The deal combines Voiant’s clinical trial imaging expertise with Voxeleron’s cloud-based image analysis tools to accelerate biomarker development, improve data accuracy, and enhance ophthalmology-focused clinical research services.
- Buyers
- Voiant
- Targets
- Voxeleron
- Industry
- AI & Machine Learning
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.